ONC
NASDAQStockBeOne Medicines Ltd.
$288.00-10.99 (-3.68%)
52-Week Range
$206.32
$377.47
Key Stats
Market Cap
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.52
Volume
198.6K
Avg Volume
331.7K
Performance
1M
-19.28%
3M
-10.58%
6M
-14.14%
YTD
-8.27%
1Y
+14.19%
3Y
+57.78%
5Y
+57.78%
Price Chart
ETF Exposure
ONC is held by 21 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.23% |
| BBH | VanEck Biotech ETF | 3.13% |
| AGNG | Global X - Aging Population ETF | 2.40% |
| IBB | iShares Biotechnology ETF | 1.92% |
| CANC | Tema Oncology ETF | 1.73% |
| EMEQ | Macquarie Focused Emerging Markets Equity ETF | 0.98% |
| EEMO | Invesco S&P Emerging Markets Momentum ETF | 0.78% |
| CGGE | Capital Group Global Equity ETF | 0.64% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.50% |
| CGIE | Capital Group International Equity ETF | 0.50% |
| HELX | Franklin Genomic Advancements ETF | 0.29% |
| SPWO | SP Funds S&P World (ex-US) ETF | 0.27% |
| CGNG | Capital Group New Geography Equity ETF | 0.26% |
| NTSE | WisdomTree Emerging Markets Efficient Core Fund | 0.17% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.11% |
| DFSE | Dimensional - Emerging Markets Sustainability Core 1 ETF | 0.08% |
| DFAE | Dimensional - Emerging Core Equity Market ETF | 0.04% |
| DFEM | Dimensional - Emerging Markets Core Equity 2 ETF | 0.03% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.02% |
| PXF | Invesco RAFI Developed Markets ex-U.S. ETF | 0.01% |
| DFAX | Dimensional - World ex US Core Equity 2 ETF | 0.01% |
About ONC ETF Exposure
BeOne Medicines Ltd. (ONC) is held by 21 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $288.00. Investors can gain exposure to ONC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ONC, sorted by portfolio weight.